Development and evaluation of sustained release tablets of Mebeverine hydrochloride

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2014, Vol 2, Issue 6

Abstract

The objective of present investigation is to develop and evaluate development and evaluation of sustained release matrix tablets of Mebeverine hydrochloride to achieve sustained drug release with reduced frequency of drug administration, reduced side effects and patient compliance and to prolong the drug release in GIT and consequently into the plasma. Sustained release matrix tablets of Mebeverine hydrochloride were prepared by using polymers like hpmc k100, ethyl cellulose, micro crystalline cellulose, talc, magnesium stearate, guar gum and starch. Mebeverine is an antispasmodic agent which exerts direct action on the GIT smooth muscle. Rapidly absorbed from the GI tract (oral); peak plasma concentrations within 1-3 hr. Mebeverine hydrochloride sustained release matrix tablets were prepared by direct compression method. The powder blend was subjected for pre-compressional parameters such as bulk density and tapped density, angle of repose, compressibility index and Hausner’s ratio. The prepared tablets are evaluated to post-compressional parameters such as hardness, friability, average weight, uniformity of weight and invitro dissolution studies. Drug compatibility with excipients was checked by FTIR studies. The values of precompressional parameters evaluated were with in prescribed limits and indicated good free flowing property. The values of post-compressional parameters evaluated were within acceptable limits. The dissolution profiles of all the formulations were evaluated. Amongst all the formulations, the release profile of formula f6 gave optimum results. It was concluded that Mebeverine hydrochloride sustained release matrix tablets, f6 is successful formulation and can be manufactured with reproducible characteristics from batch to batch. The optimized formulation (F6) was compared to the marketed product and hence found to be superior over the marketed product.

Authors and Affiliations

Mohammad Atheequr Rahman, B. Pragati Kumar, Aarif Baha

Keywords

Related Articles

Conservative management of allergic respiratory illness in the light of Ayurveda & Plant Biotechnology: A literary review

The term Allergy refers to expression of an ‘altered state of reactivity’ to common environmental antigens. Allergic diseases have a familial predisposition and common target organs are lungs, nose and skin. Common all...

Role of Presynaptic receptors in health and disease

Maintenance of homeostasis is the norm of nature. In order to maintain homeostasis in neuronal transmission, fine tuning of neurotransmitter release from the presynaptic nerve terminals is required. This role is played...

COMPARISION OF POTENCY OF ANTI BACTERIAL ACTIVITY AND ANTI INFLAMMATORY ACTIVITY OF 10 YEARS AND 100 YEARS OLD BARK EXTRACTS OF AZADIRACHTA INDICA

Azadirachta indica (Meliaceae) commonly known as neem contains many biologically active compounds including alkaloids, flavonoids, triterpenoids, phenolic compounds, Carotenoids, steroids and ketones, azadirachtin. Oil...

Reproductive ecology of leucas aspera (wild) link (Lamiaceae)

Leucas aspera is commonly known as Thummi chettu. The plants flower once in a year during September – February. The flowers are white sessile small zygomorphic, bilabiate,gullet shaped produced in verticils of terminal...

RP-HPLC method for simultaneous estimation of Candesartan and Amlodipine in bulk and pharmaceutical dosage forms

A simple, rapid, accurate and precise isocratic reversed phase high performance liquid chromatographic method has been developed and validated for simultaneous estimation of Candesartan and Amlodipine in tablet dosage...

Download PDF file
  • EP ID EP33269
  • DOI -
  • Views 253
  • Downloads 0

How To Cite

Mohammad Atheequr Rahman, B. Pragati Kumar, Aarif Baha (2014). Development and evaluation of sustained release tablets of Mebeverine hydrochloride. Indian Journal of Research in Pharmacy and Biotechnology, 2(6), -. https://europub.co.uk/articles/-A-33269